Zobrazeno 1 - 10
of 10
pro vyhledávání: '"G R, Higgins"'
Autor:
G. R. Higgins, J.W. Parker, R. J. Lukes, V. Swanson, Clive R. Taylor, Thomas L. Lincoln, Stebbins B. Chandor, John J. Quinn, Arthur H. Williams, Darleen R. Powars, Barbara H. Tindle, Paul K. Pattengale, Barbara K. Schneider
Publikováno v:
Cancer. 42:171-181
Publikováno v:
Archives of pathologylaboratory medicine. 106(9)
The histopathologic aspects of 62 cases of chronic active hepatitis (CAH) were examined to compare hepatitis B surface antigen (HBsAg)-positive with HBsAg-negative (non-A, non-B) cases. Epidemiologically, the two groups were distinct. Homosexuals and
Autor:
L J, Ettinger, S E, Siegel, J B, Belasco, A E, Evans, K S, Ruccione, D C, Jamin, T M, Rohrbaugh, G R, Higgins
Publikováno v:
Cancer treatment reports. 69(3)
Diaziquone (AZQ), a new lipid-soluble antitumor agent, was given by 15-30-minute infusion on a daily X 5 schedule to 47 children with refractory solid tumors and leukemia. The starting daily dose of 6 mg/m2 was escalated to 10 and 35 mg/m2 in patient
Publikováno v:
The American journal of pediatric hematology/oncology. 5(3)
A retrospective analysis of 125 consecutive cases of Hodgkin's disease, seen at a pediatric institution, was conducted and 28 patients under the age of 7 years (young children) were selected for comparison with a control population, aged 7 or more ye
Publikováno v:
Cancer treatment reports. 64(4-5)
A phase I trial of diglycoaldehyde (Inox) in children with leukemia established that the maximum tolerated dose of a 5-day schedule was 1.5 g/m2/day. A phase II study was undertaken by the Children's Cancer Study Group to evaluate the efficacy of thi
Publikováno v:
American journal of mental deficiency. 78(4)
Autor:
A H, Williams, C R, Taylor, G R, Higgins, J J, Quinn, B K, Schneider, V, Swansson, J W, Parker, P K, Pattengale, S B, Chandor, D, Powars, T L, Lincoln, B H, Tindle, R J, Lukes
Publikováno v:
Cancer. 42(1)
Publikováno v:
Cancer treatment reports. 69(6)
Thirty-one pediatric patients with acute leukemia who had relapsed on either 6-mercaptopurine or 6-thioguanine were treated with beta-2'-deoxythioguanosine, which was administered as an iv infusion every 12 hours for three or six doses every 2 weeks.
Publikováno v:
Cancer. 20(10)
Autor:
M H, Freedman, J Z, Finklestein, G S, Gilchrist, G D, Hammond, G R, Higgins, C B, Hyman, N A, Shore, K O, Williams, M R, Karon
Publikováno v:
Cancer chemotherapy reports. 53(5)